Speech-Language Pathologists in Pomeroy, OH Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Meghan Goeglein Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 41765 Pomeroy Pike, Pomeroy, OH 45769 Phone: 740-992-2153

Mr. Nicholas J Weiland, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 E Memorial Dr, Suite A, Pomeroy, OH 45769 Phone: 740-593-1404    Fax: 740-593-4433

Ms. Maureen Ella Hennessy, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 36759 Rocksprings Rd, Pomeroy, OH 45769 Phone: 740-992-6606    Fax: 740-992-2678

Mrs. Jessica Katherine Elaine Barnett, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 36759 Rocksprings Rd, Pomeroy, OH 45769 Phone: 740-992-2678

Cheryl Ann King Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 37840 State Route 124, Pomeroy, OH 45769 Phone: 740-416-6336

Mrs. Jennifer L Case, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 36759 Rocksprings Rd, Pomeroy, OH 45769 Phone: 740-992-6606

News Archive

Perspectives on the court and the health law: Is this judicial activism?; Decision could define Roberts; Health economics 101

The ideological nature of the health care case was obvious on the last day of oral argument. By the time the proceedings were over, much of what the conservative justices said in court seemed like part of a politically driven exercise -; especially because the issues addressed on Wednesday were not largely constitutional in nature.

Mettler Toledo provide resource on the importance of calibrating weighing devices

Periodic calibration of weighing equipment is the first step to accurate and reliable results and the most cost-effective way to optimize an investment. Read "Calibrating Your Weighing Devices Ensures Accurate Results", from METTLER TOLEDO's free online laboratory expertise library to learn the benefits of calibration and routine testing, understand the risks associated with using non-calibrated equipment, and recognize the difference between calibration and adjustment.

New analyses of long-term LIALDA (mesalamine) data presented at ACG

Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis (UC) drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis.

Texas Biomed to investigate the effects of cannabinoids on HIV-associated neurocognitive disorder

The National Institutes of Health (NIH) awarded Professor Mahesh Mohan, D.V.M., Ph.D., and collaborators more than $3.5 million over five years to investigate the effects of cannabinoids on Human Immunodeficiency Virus (HIV) associated neurocognitive disorder (HAND).

Watson receives FDA approval for generic Fentora

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.

Read more Medical News

› Verified 4 days ago